Profile data is unavailable for this security.
About the company
Frontage Holdings Corporation is a holding company. The principal activities of the Company and its subsidiaries are to provide laboratory and related services to pharmaceutical and agrochemical companies. The Company is a contract research organization (CRO) providing integrated, science-driven, product development services throughout the drug discovery and development process to enable life science companies to achieve their drug development goals. Its segments include North America and the People’s Republic of China (PRC). The North America segment includes laboratory testing, chemistry, manufacturing and control (CMC), preclinical research, early stage clinical/bioequivalence and chemistry services in the USA and Canada. PRC segments include laboratory testing, CMC, preclinical research, early stage clinical/ bioequivalence and chemistry services in the PRC. Its preclinical research services consist of drug metabolism and pharmacokinetic (DMPK) and safety and toxicology.
- Revenue in HKD (TTM)2.03bn
- Net income in HKD84.45m
- Incorporated2018
- Employees1.76k
- LocationFrontage Holdings Corp700 Pennsylvania DrExton 19341-1129United StatesUSA
- Phone+1 (610) 232-0100
- Fax+1 (610) 232-0101
- Websitehttps://www.frontagelab.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mabpharm Ltd | 94.33m | -226.57m | 1.55bn | 347.00 | -- | 6.97 | -- | 16.39 | -0.055 | -0.055 | 0.0229 | 0.0538 | 0.0893 | 0.1176 | 6.02 | 271,843.40 | -21.44 | -21.42 | -28.92 | -27.49 | 86.32 | -- | -240.19 | -486.40 | 0.7596 | -19.03 | 0.5591 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
| Hua Medicine | 82.91m | -228.61m | 1.60bn | 177.00 | -- | 13.59 | -- | 19.35 | -0.2339 | -0.2339 | 0.0849 | 0.1119 | 0.0538 | 1.69 | 1.98 | 468,423.00 | -14.84 | -25.61 | -17.56 | -28.81 | 48.78 | -- | -275.73 | -1,654.70 | 6.06 | -- | 0.6238 | -- | 335.31 | -- | -3.80 | -- | -- | -- |
| Immunotech Biopharm Ltd | 0.00 | -362.36m | 1.74bn | 210.00 | -- | 9.28 | -- | -- | -0.7042 | -0.7042 | 0.00 | 0.3651 | 0.00 | -- | -- | 0.00 | -38.88 | -37.42 | -50.88 | -45.48 | -- | -- | -- | -- | 1.03 | -1.97 | 0.4327 | -- | -- | -- | -5.25 | -- | -- | -- |
| Dawnrays Pharmaceutical (Holdings) Ltd | 1.25bn | 352.81m | 1.82bn | 1.14k | 5.16 | 0.5876 | 4.01 | 1.46 | 0.2347 | 0.2347 | 0.8291 | 2.06 | 0.3156 | 2.31 | 6.37 | 1,089,958.00 | 8.85 | 9.89 | 11.36 | 12.49 | 54.60 | 56.69 | 28.03 | 27.89 | 2.26 | 28.89 | 0.0405 | 35.33 | -9.90 | 3.94 | -8.95 | 1.41 | 63.92 | 2.00 |
| Cryofocus Medtech Shanghai Co Ltd | 44.32m | -105.50m | 1.89bn | 392.00 | -- | 10.81 | -- | 42.62 | -0.4412 | -0.4412 | 0.1854 | 0.7308 | -- | -- | -- | 113,056.10 | -- | -- | -- | -- | 75.83 | -- | -258.23 | -- | 4.08 | -- | 0.0597 | -- | 50.83 | -- | 13.13 | -- | -- | -- |
| SinoMab Bioscience Ltd | 1.48m | -263.11m | 2.02bn | 233.00 | -- | 5.99 | -- | 1,367.22 | -0.2584 | -0.2584 | 0.0015 | 0.3091 | 0.0015 | -- | -- | -- | -26.20 | -24.62 | -32.50 | -27.72 | 30.92 | -- | -17,810.33 | -4,451.74 | -- | -8.15 | 0.604 | -- | -- | -- | 14.45 | -- | -- | -- |
| Acotec Scientific Holdings Ltd | 512.82m | 15.68m | 2.02bn | 638.00 | 123.70 | 1.44 | 30.75 | 3.94 | 0.0521 | 0.0521 | 1.70 | 4.48 | 0.3136 | 0.7213 | 3.44 | 803,793.30 | 0.9589 | -- | 1.03 | -- | 79.65 | -- | 3.06 | -- | 9.12 | 2.75 | 0.1529 | -- | 19.80 | -- | -79.35 | -- | -- | -- |
| Cutia Therapeutics | 148.94m | -2.13bn | 2.16bn | 298.00 | -- | 1.47 | -- | 14.49 | -6.99 | -6.99 | 0.4899 | 4.80 | -- | -- | -- | 499,805.20 | -- | -- | -- | -- | 51.60 | -- | -1,426.91 | -- | 5.38 | -- | 0.153 | -- | 1,110.83 | -- | -253.30 | -- | -- | -- |
| Abbisko Cayman Ltd | 20.63m | -467.08m | 2.42bn | 258.00 | -- | 1.13 | -- | 117.44 | -0.7217 | -0.7217 | 0.0319 | 3.06 | 0.0083 | -- | 1.40 | 79,951.98 | -18.74 | -- | -19.67 | -- | 100.00 | -- | -2,264.34 | -- | -- | -- | 0.0177 | -- | -- | -- | 12.92 | -- | -- | -- |
| Peijia Medical Ltd | 477.41m | -424.81m | 2.49bn | 1.04k | -- | 1.01 | -- | 5.21 | -0.6255 | -0.6255 | 0.7028 | 3.62 | 0.1473 | 0.7773 | 9.51 | 459,045.10 | -13.11 | -34.08 | -14.94 | -36.90 | 73.76 | 71.62 | -88.99 | -448.75 | 6.92 | -- | 0.0886 | -- | 75.86 | -- | 3.75 | -- | -- | -- |
| Frontage Holdings Corp | 2.03bn | 84.45m | 2.50bn | 1.76k | 30.10 | 0.9348 | 6.92 | 1.23 | 0.0409 | 0.0409 | 0.981 | 1.32 | 0.463 | 60.63 | 5.32 | 1,154,294.00 | 1.91 | 4.46 | 2.33 | 5.28 | 30.17 | 34.00 | 4.13 | 9.92 | 1.39 | 4.09 | 0.296 | 0.00 | 3.79 | 25.61 | -58.00 | -0.7826 | 40.43 | -- |
| Laekna Inc | 0.00 | -399.15m | 2.57bn | 89.00 | -- | 2.95 | -- | -- | -3.31 | -3.31 | 0.00 | 2.23 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -5.28 | 0.0655 | -- | -- | -- | 52.81 | -- | -- | -- |
| MicroPort CardioFlow Medtech Corp | 363.87m | -510.32m | 2.75bn | 592.00 | -- | 1.09 | -- | 7.56 | -0.2159 | -0.2159 | 0.154 | 1.05 | 0.1205 | 2.78 | 3.67 | 614,640.80 | -16.91 | -17.37 | -18.11 | -22.96 | 2.06 | -1.67 | -140.25 | -180.82 | 9.91 | -11.56 | 0.0293 | -- | 33.94 | -- | -3.77 | -- | -14.16 | -- |
| Golden Throat Holdings Group Co Ltd | 1.04bn | 270.74m | 2.84bn | 869.00 | 10.49 | 1.69 | 9.07 | 2.73 | 0.3662 | 0.3662 | 1.41 | 2.27 | 0.4181 | 4.82 | 1.85 | 1,197,292.00 | 10.88 | 11.00 | 15.85 | 15.63 | 72.57 | 72.79 | 26.02 | 24.67 | 2.48 | 34.74 | 0.21 | 83.15 | -3.09 | 6.73 | -11.04 | 19.61 | -32.13 | 38.94 |
| HighTide Therapeutics Inc | 0.00 | -594.96m | 3.48bn | 66.00 | -- | 4.20 | -- | -- | -1.26 | -1.26 | -- | 1.61 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -0.3798 | 0.0229 | -- | -- | -- | -393.76 | -- | -- | -- |
| China Isotope & Radiation Corp | 7.18bn | 401.48m | 3.52bn | 3.11k | 8.76 | 0.6927 | 3.24 | 0.49 | 1.26 | 1.26 | 22.45 | 15.88 | 0.5312 | 4.22 | 1.84 | 2,312,623.00 | 6.21 | 6.57 | 12.82 | 13.26 | 52.48 | 59.89 | 11.70 | 12.62 | 1.73 | -- | 0.1919 | 28.27 | 7.82 | 15.35 | -5.43 | 2.88 | 3.63 | 2.92 |
Data as of May 10 2024. Currency figures normalised to Frontage Holdings Corp's reporting currency: Hong Kong Dollar HKD
7.14%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Grandeur Peak Global Advisors LLCas of 31 Jan 2024 | 50.21m | 2.39% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 21.32m | 1.02% |
| UBS SDIC Fund Management Co., Ltd.as of 30 Jun 2023 | 19.99m | 0.95% |
| Fidelity Management & Research (Hong Kong) Ltd.as of 31 Mar 2024 | 18.77m | 0.89% |
| First Seafront Fund Management Co., Ltd.as of 30 Jun 2023 | 8.91m | 0.43% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2022 | 7.29m | 0.35% |
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 6.66m | 0.32% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 6.29m | 0.30% |
| GF Fund Management Co., Ltd.as of 30 Jun 2022 | 6.08m | 0.29% |
| Fidelity Management & Research Co. LLCas of 29 Feb 2024 | 4.36m | 0.21% |
More ▼
Data from 30 Jun 2023 - 02 May 2024Source: FactSet Research Systems Inc.
